Publikasi

Looking Back on Presidential Term: Highlights Include S...

As my presidential term winds down, I look back with pride and admiration at the...

Happy National Dental Hygienist and Dental Therapist Day! 

Today we celebrate National Dental Hygienist and Dental Therapist Day, recognisi...

BIO on the American Road tours gene therapy hub in Ohio

Ohio’s diverse biotech sector provides the state with employment for 65,000 and ...

Collaboration vs. Coordination

R&D efficiency and productivity are among the biggest challenges in drug discove...

What’s Next in the Evolution of Standards for Biologics...

Fouad Atouf, PhD, CSO of United States Pharmacopeia (USP) feels the growing com...

Conserved Protein May Transform Anti-Inflammatory Strat...

Plasma gelsolin is generally overlooked by researchers, but is a key regulator o...

Big Improvements for CGT Manufacturing as Development S...

Manufacturing advances are coming to the aid of cell and gene therapy developers...

Smarter AAVs Drive Gene Therapy’s Next Chapter

Advances in viral-vector engineering, analytics, and scalable manufacturing are ...

Gene Editing at Scale, Clinic Seeks Generalizable Thera...

What’s most exciting about CRISPR is its potential to shift medicine from managi...

Breaking Through the Barrier

The right approaches are demonstrating that it is possible to breach the defensi...

Going Non-Viral: Gene Delivery Enters Its Translation Era

Advanced non-viral gene delivery systems are expanding the range of indications ...

Top 10 Best Selling Gene Therapies

As more products reach the market, therapy developers partner with researchers a...

Approaches to Reducing Toxicity and Side Effects in Cel...

Companies are adopting diverse approaches to reducing unwanted toxicities associ...

Dental practice profits recover across all sectors in N...

Dental practice profits rebounded across private and mixed practices in 2025, wi...

LEO Pharma to acquire gene therapy company Replay

The acquisition aims to strengthen LEO Pharma’s capabilities while leveraging Re...

Axsome receives FDA approval for Auvelity to treat Alzh...

Auvelity is a first-in-class therapy targeting both N-methyl D-aspartate (NMDA) ...